Nestle to buy vitamin maker Atrium Innovations for $2.3 billion

Nestle is paying $2.3 billion to buy Canadian vitamin maker Atrium Innovations, it said on Tuesday, expanding its presence in the consumer healthcare market as it seeks to offset weakness in its&he...

 8 Views    0 Like    0 comment

Galectin slumps after NASH drug misses main goal of mid-stage trial

Galectin Therapeutics Inc said its drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goa...

 12 Views    0 Like    0 comment

Shire in deal to develop a new way to administer hemophilia drug

Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A.

 8 Views    0 Like    0 comment

Galectin says NASH drug misses main goal of midstage trial

Galectin Therapeutics Inc said on Tuesday its experimental drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed...

 6 Views    0 Like    0 comment

Philippines halts sale of dengue vaccine as Sanofi downplays risk

The Philippines has ordered French drugmaker Sanofi to stop the sale, distribution and marketing of its Dengvaxia dengue vaccine in the country after the company last week warned it could worsen th...

 6 Views    0 Like    0 comment

WHO backs Philippines suspension of Sanofi's dengue vaccine

The World Health Organization supported a decision by the Philippines Department of Health on Tuesday to suspend vaccinations with Sanofi's dengue drug Dengvaxia, the WHO said in a statement.

 7 Views    0 Like    0 comment

Trial results of Zika vaccine Sanofi dropped show promise

A Zika vaccine Sanofi SA dropped in September under political pressure over pricing produced strong responses in more than 90 percent of those taking part in an early-stage clinical trial, U.S.&hel...

 10 Views    0 Like    0 comment

Court-mandated opioid rehab rarely meets medical standards

By Lisa Rapaport(Reuters Health) - Fewer than one in 20 people with opioid addiction problems who are ordered into rehab programs by the courts recei

 8 Views    0 Like    0 comment

Montana sues OxyContin maker Purdue over opioid epidemic

Montana has sued OxyContin maker Purdue Pharma LP, withdrawing from a multistate investigation by attorneys general into opioid manufacturers' marketing practices, joining a growing list of states&...

 6 Views    0 Like    0 comment

Trouble mounts for Sanofi dengue vaccine over safety concerns

The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive…

 6 Views    0 Like    0 comment

Tattooed wish for withholding treatment not good enough, doctors say

By Gene Emery(Reuters Health) - Consumers are often told, "Put it in writing." But in the case of a hospitalized Florida man facing death, displaying

 5 Views    0 Like    0 comment

Healthcare prices hard to find online

By Lisa RapaportReuters Health - Consumers who search online for prices of common medical procedures may be disappointed by what they find, a U.S. st

 7 Views    0 Like    0 comment